These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28880267)

  • 41. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
    Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
    Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming.
    Tanaka Y; Hysolli E; Su J; Xiang Y; Kim KY; Zhong M; Li Y; Heydari K; Euskirchen G; Snyder MP; Pan X; Weissman SM; Park IH
    Stem Cell Reports; 2015 Jun; 4(6):1125-39. PubMed ID: 26004630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.
    Brouwer M; Zhou H; Nadif Kasri N
    Stem Cell Rev Rep; 2016 Feb; 12(1):54-72. PubMed ID: 26424535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polycomb Group Protein Pcgf6 Acts as a Master Regulator to Maintain Embryonic Stem Cell Identity.
    Yang CS; Chang KY; Dang J; Rana TM
    Sci Rep; 2016 Jun; 6():26899. PubMed ID: 27247273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3.
    Alaei S; Knaupp AS; Lim SM; Chen J; Holmes ML; Änkö ML; Nefzger CM; Polo JM
    Stem Cell Res; 2016 Jul; 17(1):49-53. PubMed ID: 27558603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of iPS cell generation and beyond.
    Kaji K
    Keio J Med; 2017; 66(1):14. PubMed ID: 28356547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.
    Vallier L; Touboul T; Brown S; Cho C; Bilican B; Alexander M; Cedervall J; Chandran S; Ahrlund-Richter L; Weber A; Pedersen RA
    Stem Cells; 2009 Nov; 27(11):2655-66. PubMed ID: 19688839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
    Oh HR; Kim J; Kim J
    FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
    Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
    Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming.
    Wu Y; Li Y; Zhang H; Huang Y; Zhao P; Tang Y; Qiu X; Ying Y; Li W; Ni S; Zhang M; Liu L; Xu Y; Zhuang Q; Luo Z; Benda C; Song H; Liu B; Lai L; Liu X; Tse HF; Bao X; Chan WY; Esteban MA; Qin B; Pei D
    Nat Cell Biol; 2015 Jun; 17(6):715-25. PubMed ID: 25985393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
    Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
    Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Iskender B; Izgi K; Canatan H
    Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.
    Sui D; Sun Z; Xu C; Wu Y; Capecchi MR; Wu S; Li N
    Stem Cell Reports; 2014 May; 2(5):721-33. PubMed ID: 24936457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SCNT versus iPSCs: proteins and small molecules in reprogramming.
    Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
    Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Derivation of LIF-independent mouse iPS cells with modified Oct4.
    Hirai H; Firpo M; Kikyo N
    Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
    Alexandrova EM; Moll UM
    Methods Mol Biol; 2013; 962():157-64. PubMed ID: 23150445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.